Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04407546 · ClinicalTrials.gov registry record

Role of Children in Transmission of COVID-19 to Immunocompromised Patients

A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.

Terminated
Registry status
109
Enrollment target

NCT04407546: Clinical Trial study, sponsored by Jonsson Comprehensive Cancer Center.

NCT04407546 is a clinical trial that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04407546 was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.

TERMINATED
Registry status
109 participants
Enrollment target

Study Summary

This is a study of immunosuppressed individuals living in households with and without children to assess the role of household contact with children in the transmission of SARSCoV-2 to immunocompromised individuals. Through careful collection of epidemiological data in combination with biological specimens, risk factors for SARS-CoV-2 in immunocompromised individuals will be identified. During the initial visits, informed consent will be obtained and consented participants will complete an initial questionnaire and provide biological specimens including nasal swabs, saliva and blood. Thereafter, participants will complete at-home saliva collections and questionnaires on a weekly basis for 6 months. If our research-use only SARS-CoV-2 test is positive, participants will be referred immediately for medical attention and will be followed every 3 days with nasal swabs and saliva samples and weekly blood specimens and optional rectal swabs or fresh stool collection. Additionally, participants will be contacted by telephone at 1 year for follow-up.

Primary Outcome

Measure the incidence of transmission of SARS-CoV-2 to immunocompromised patients in households with children compared to households without children

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2020-05-27
Est. Completion 2023-03-13
Jonsson Comprehensive Cancer Center

321 total trials

Why NCT04407546 stopped before completion

NCT04407546 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT04407546 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04407546 about?

NCT04407546 is a clinical study titled "Role of Children in Transmission of COVID-19 to Immunocompromised Patients". This is a study of immunosuppressed individuals living in households with and without children to assess the role of household contact with children in the transmission of SARSCoV-2 to immunocompromised individuals. Through careful collection of epidemiological data in combination with biological sp...

What is the current status of trial NCT04407546?

This trial is currently terminated. The enrollment target is 109 participants. The study started on 2020-05-27. Estimated completion is 2023-03-13.

Who is sponsoring clinical trial NCT04407546?

This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04407546, the US trial registry maintained by the National Library of Medicine. NCT04407546 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.